Hydrogen sulfide treatment improves long-term renal dysfunction resulting from prolonged warm renal ischemia-reperfusion injury
Authors:
- Weihau LiuWLWeihau Liu
- Alp SenerASAlp Sener
Open Access
- 16 June 2014
- journal article
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 8 (5-6) , 413-8
Abstract
Introduction: The incidence of renal cell carcinoma (RCC) continues to rise concurrently with the increased prevalence of end-stage renal disease worldwide. Treatment for small renal masses continues to be partial nephrectomy mostly involving the clamping of renal blood vessels. Although necessary, this technique results in warm renal ischemia and reperfusion injury (IRI) to the afflicted kidney. We have recently demonstrated that hydrogen sulfide (H2S), a novel endogenous gaseous molecule, protects against prolonged cold and short-term warm renal IRI. In the current study, we examined whether exogenous H2S has long-term protective effects against warm renal IRI associated with renal surgical procedures.Methods: Uni-nephrectomized Lewis rats underwent 1 hour of warm ischemia induced by clamping of the renal pelvis. Animals underwent either intraperitoneal treatment with phosphate buffered saline (PBS; IRI group) or PBS supplemented with 150 μM NaHS (H2S group), and were compared against Sham-operated rats.Results: H2S treatment improved long-term renal function as serum creatinine at day 7 was significantly decreased in the H2S group compared to IRI animals (p < 0.05). H2S treatment decreased the expression of pro-inflammatory markers TLR-4, TNF-α, IFNγ, IL-2and ICAM-1, increased the expression of pro-survival molecule Bcl-2 and decreased the expression of pro-apoptotic marker BID at postoperative day 1. H2S-treated kidneys also showed a significant decrease (p < 0.05) in infiltration of macrophages at day 7 post-IRI compared to no treatment.Conclusion: H2S treatment improved long-term renal function and decreased long-term inflammation associated with warm IRI, and may offer a novel therapeutic approach to preventing warm IRI-induced renal injury associated with renal surgical procedures.Keywords
This publication has 32 references indexed in Scilit:
- Every Minute Counts When the Renal Hilum Is Clamped During Partial NephrectomyEuropean Urology, 2010
- Hydrogen sulphide ameliorates ischaemia–reperfusion injury in an experimental model of non-heart-beating donor kidney transplantationBritish Journal of Surgery, 2010
- Hydrogen Sulfide Inhibits Rotenone-Induced Apoptosis via Preservation of Mitochondrial FunctionMolecular Pharmacology, 2009
- Generation of endogenous hydrogen sulfide by cystathionine γ-lyase limits renal ischemia/reperfusion injury and dysfunctionLaboratory Investigation, 2008
- Hydrogen sulfide protects rat lung from ischemia–reperfusion injuryLife Sciences, 2008
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Endogenous production of hydrogen sulfide in mammalsAmino Acids, 2004
- Two's company, three's a crowd: can H 2 S be the third endogenous gaseous transmitter?The FASEB Journal, 2002
- Global increases in kidney cancer incidence, 1973–1992European Journal Of Cancer Prevention, 2002
- Reactive oxygen species and acute renal failureThe American Journal of Medicine, 2000